The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So, we prefer, for example, we always prefer to go with where we have human evidence, then there are no consequences and there's a growth hormone receptor, right? So, we're not developing drugs against growth hormone receptor, why? Because we have the Ecuadorean that we've been following for 10 years, and Guevara, our colleagues, has been following them for 30 years. And that's fine, they make it to very old age.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.